These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12410731)

  • 21. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
    Simpson D; Lyseng-Williamson KA
    Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials.
    Tyring SK; Diaz-Mitoma F; Shafran SD; Locke LA; Sacks SL; Young CL
    J Cutan Med Surg; 2003; 7(6):449-54. PubMed ID: 15931690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in meeting today's demands in genital herpes: an overview of current management.
    Patel R
    J Infect Dis; 2002 Oct; 186 Suppl 1():S47-56. PubMed ID: 12353187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
    Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
    AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Famciclovir for cutaneous herpesvirus infections: an update and review of new single-day dosing indications.
    Chacko M; Weinberg JM
    Cutis; 2007 Jul; 80(1):77-81. PubMed ID: 17725069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy for genital herpes in immunocompromised patients: a national survey. The Herpes Simplex Advisory Panel.
    Scoular A; Barton S
    Genitourin Med; 1997 Oct; 73(5):391-3. PubMed ID: 9534751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of viral DNA to evaluate outcome of antiviral treatment of patients with recurrent genital herpes.
    Diaz-Mitoma F; Ruben M; Sacks S; MacPherson P; Caissie G
    J Clin Microbiol; 1996 Mar; 34(3):657-63. PubMed ID: 8904433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of oral acyclovir and imiquimod for the treatment of hypertrophic genital herpes simplex in HIV positive patients: report of two cases.
    Barbosa Ldo N; Souto R; Furtado AL; Gripp AC; Daxbacher E
    An Bras Dermatol; 2011; 86(5):1043-5. PubMed ID: 22147057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertrophic perianal herpes successfully treated with imiquimod.
    Lestre SI; João A; Carvalho C; Serrão VV
    An Bras Dermatol; 2011; 86(6):1185-8. PubMed ID: 22281910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The continuing evolution of antiviral therapy for recurrent genital herpes: 1-day patient-initiated treatment with famciclovir.
    Aoki FY
    Herpes; 2007 Dec; 14(3):62-5. PubMed ID: 18371288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral treatment of genital herpes.
    Apoola A; Radcliffe K
    Int J STD AIDS; 2004 Jul; 15(7):429-33. PubMed ID: 15228725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial.
    Chosidow O; Drouault Y; Leconte-Veyriac F; Aymard M; Ortonne JP; Pouget F; Revuz J; Decazes JM; Malkin JE
    Br J Dermatol; 2001 Apr; 144(4):818-24. PubMed ID: 11298543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the care of patients with genital herpes.
    Drake S; Taylor S; Brown D; Pillay D
    BMJ; 2000 Sep; 321(7261):619-23. PubMed ID: 10977846
    [No Abstract]   [Full Text] [Related]  

  • 35. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
    Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
    JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective.
    Vinh DC; Aoki FY
    Expert Opin Pharmacother; 2006 Nov; 7(16):2271-86. PubMed ID: 17059383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
    Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
    McKendry A; Narayana S; Browne R
    Int J STD AIDS; 2015 May; 26(6):441-3. PubMed ID: 24912536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of herpes simplex & varicella zoster infection.
    Barrg C; Sheehan G
    Ir Med J; 1996; 89(4):132-4. PubMed ID: 8824033
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.
    Sacks SL; Aoki FY; Martel AY; Shafran SD; Lassonde M
    Clin Infect Dis; 2005 Oct; 41(8):1097-104. PubMed ID: 16163627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.